Eledon Pharmaceuticals, Inc. (NVUS): Price and Financial Metrics


Eledon Pharmaceuticals, Inc. (NVUS): $14.60

-0.80 (-5.19%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NVUS to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

NVUS Stock Price Chart Interactive Chart >

Price chart for NVUS

NVUS Price/Volume Stats

Current price $14.60 52-week high $27.32
Prev. close $15.40 52-week low $4.50
Day low $14.60 Volume 87,000
Day high $15.77 Avg. volume 0
50-day MA $19.62 Dividend yield N/A
200-day MA $13.14 Market Cap 20.97M

Eledon Pharmaceuticals, Inc. (NVUS) Company Bio


Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease.


NVUS Latest News Stream


Event/Time News Detail
Loading, please wait...

NVUS Latest Social Stream


Loading social stream, please wait...

View Full NVUS Social Stream

Latest NVUS News From Around the Web

Below are the latest news stories about Novus Therapeutics Inc that investors may wish to consider to help them evaluate NVUS as an investment opportunity.

Novus Therapeutics (NVUS) Investor Presentation - Slideshow

The following slide deck was published by Novus Therapeutics, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | December 18, 2020

Read More 'NVUS' Stories Here

NVUS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -52.29%
5-year -83.51%
YTD N/A
2021 0.00%
2020 47.51%
2019 -63.75%
2018 -60.59%
2017 -53.97%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6591 seconds.